Archive: 03/30/2011

Researchers publish molecular disease model for melanoma

Cancer Commons, an initiative of CollabRx, a provider of information technology to personalize cancer treatments and accelerate research, announces the publication of a molecular disease model of melanoma (MDMM) which classifies ...

Mar 30, 2011
5 / 5 (1) 0

Medicare to pay for $93,000 prostate cancer drug

(AP) -- Medicare officials said Wednesday that the program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that gives men suffering from the disease an extra four months to live, on average.

Mar 30, 2011
not rated yet 1